Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein regulatory complex subunit 7 (DRC7) is a critical structural subunit of the nexin–dynein regulatory complex (N-DRC), a multi-protein assembly bridging adjacent doublet microtubules within the axoneme of motile cilia and flagella[1][3][4][6][7]. DRC7, the largest N-DRC component (~177 kDa), contains a highly conserved transglutaminase-like domain that likely interacts with glutamylated proteins in the microtubule cytoskeleton[2]. Its primary roles are maintaining the alignment and integrity of axonemal microtubule doublets, stabilizing the axonemal core, and regulating dynein-driven ciliary and flagellar movement. DRC7 is vital for proper sperm flagellum assembly, with knockout models in mice showing disorganized axonemes, immotile sperm, and infertility[1][5]. Deficiencies or mutations in DRC7 disrupt ciliary motility and structural integrity, implicating this protein in genetic forms of ciliopathies and reproductive failure, although DRC7 itself is not currently a therapeutic or diagnostic target in clinical medicine.
Not applicable. DRC7 is not a therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein regulatory complex subunit 7 (DRC7).